Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
New information in the 10Q......
Sam Gaer continues to fund TGFN with convertible debt at .01/share. Another $12K on November 13, subsequent to the end of the third quarter.
Also, an interesting bit of information was disclosed in the "results of operations" segment of the quarterly reply......
Marshall Butler obituary.....
Marshall Butler passed away last week at the age of 85.
Riverside Memorial obituary.....
Financial numbers...CEO photo.....
Financial numbers for the trailing 12-month period, as of Q3 2012 (September 30).....
YIHG (share price: .10)
13.3M shares outstanding
$1.33M market cap
$24M revenue
$7.4M net income
.55 EPS
.18 PE
$1.48 book value
Yakun Song (YIHG CEO) attended a donation/check presentation ceremony at Hong Kong Baptist University last week, in her role as the Honorary President/Chairman of a foundation/fund that the university has. She has donated money a couple of years ago to set up some scholarship programs. Song is the second from the left.....
http://translate.google.com/translate?hl=en&sl=zh-CN&u=http://cn.hkbu.edu.hk/mainland/index.php%3Faction%3Dview%26id%3D562&prev=/search%3Fq%3D%2522song%2Byakun%2522%26num%3D100%26hl%3Den%26lr%3Dlang_zh-CN%26safe%3Doff%26tbo%3Dd%26biw%3D1008%26bih%3D632%26tbs%3Dlr:lang_1zh-CN,qdr:y&sa=X&ei=E_umUNzjNqOXyAGsh4GIAg&ved=0CD0Q7gEwAA
Newspaper article...Li Xiaoling and Baihuazhou.....
The People's Daily Overseas Edition last week had an article about Li Xiaoling and Baihuazhou. The translation seems to be a bit more difficult than usual to understand, but the article talks about Li Xiaoling's accomplishments, bringing Baihuazhou into the public market, and some of the future development items I mentioned in the previous post.
The article contains a picture with a caption of "Baihuazhou CEO Superficial view". I'm not exactly sure who that individual is. Also contains a current photo of Li Xiaoling.....
http://translate.google.com/translate?hl=en&sl=zh-CN&u=http://news.hexun.com/2012-11-07/147672406.html&prev=/search%3Fq%3D%2522%25E7%2599%25BE%25E8%258A%25B1%25E6%25B4%25B2%25E7%25BB%25BF%25E8%2589%25B2%25E8%25B5%2584%25E6%25BA%2590%25EF%25BC%2588%25E4%25B8%25AD%25E5%259B%25BD%25EF%25BC%2589%25E6%258A%2595%25E8%25B5%2584%25E9%259B%2586%25E5%259B%25A2%25E6%259C%2589%25E9%2599%2590%25E5%2585%25AC%25E5%258F%25B8%2522%26num%3D30%26hl%3Den%26safe%3Doff%26sa%3DX%26tbo%3Dd%26biw%3D1008%26bih%3D632%26tbs%3Dqdr:w&sa=X&ei=h5acUL7QOe3ryAGKkYHgCw&ved=0CEkQ7gEwAg
db7...SN_DN shell......
temp luvs amy...reverse merger candidate.....
Navitas Capital...Southern California office.....
Somewhat interesting to note that Navitas Capital (a cleantech venture capital firm) now has an office at the "Suite 350" address. I think this occurred sometime prior to mid-2012.
http://www.navitascap.com/index.php
http://www.navitascap.com/contact.php
510(k) application(s) expected in early 2013.....
According to the VODG website, the company expects to file a 510(k) application(s) sometime during early 2013. Also, interesting to note that endothelial cells are among the differentiated cells the company expects to include in its product line (see the above post regarding an endothelial differentiation medium the company has in the product development pipeline)........
db7...CDBH shell status......
VKIN...reply to PM about previous post.....
db7...NT Publications profile of VKIN.....
It looks like VKIN has been supplying some information to NT Publications for some type of 30-day, unpaid awareness/promotion campaign starting on October 8.
Personally, I am getting more than a little annoyed/irritated by the way management of VKIN has chosen to handle a number of things regarding its business operations and disclosures of important information. From a retail investor perspective it is extremely frustrating, and it is extremely puzzling to me why management can't seem to get the message and "get its act together".
NT Publications profile.....
Quincy Tam...Noriyuki Kasahara's research lab......
In the "Customer Data" section of the Neuromics website is an image of VODG's stem cells cultured in MSC-Gro media. The image is provided by Quincy Tam (a Staff Research Associate in Noriyuki Kasahara's research laboratory)......
Some items from the Q3 filing.....
Neuromics.....
Future development plans.....
Also available on the Chinese version of the website is a list of future development plans. Value-added products/operations, bamboo processing, food production activity, etc........
Strategic agreement with Shangrao City Landscaping Authority.....
Based on a news item that appears on the Chinese version of the website, on September 12 the company entered into a long-term cooperation agreement with the Shangrao City Landscaping Authority......
Sam Gaer...CEO of Liquid Holdings Group.....
Sam Gaer (TGFN's financial backer and largest shareholder) left his position of CIO and executive vice president of FINRA in May 2012 to become the CEO of Liquid Holdings Group (a financial services firm)......
http://www.liquidholdingsgroup.com/leadership
StemGenesis...$50M project scheduled for construction......
Celartia bioreactors.....
From the 7/24/2012 VODG press release.....
Amir Gal-Or...comments about Marshall Butler.....
Amir Gal-Or's blog on the Infinity Private Equity Fund website included some comments about Marshall Butler. The "Ken Rind" referenced in the blog is "Kenneth W Rind". Rind, a former/(current?) Director of AHAG, is a well-known and extremely successful venture capitalist/investor.
Marshall Butler and Rind have been long-time investment partners and together the two probably have developed as extensive of a network of venture/investment connections as you will find. If AHAG were to ever do a reverse merger in the high technology or biotech/medical industries, Marshall would probably be a key source for that type of RM candidate. Lawrence Butler's primary areas of interest/experience I think focuses around media/consumer types of business.
Excerpt from Amir's blog (March 2012).....
Rich...International Conference on Emerging Cell Therapies...
Hemogenix CEO Ivan Rich (VODG's strategic partner) will deliver a keynote address/presentation at the 2012 International Conference on Emerging Cell Therapies (October 1, Chicago).
Subject matter of the presentation will be measurement of stem cell potency prior to therapeutic transplantation of the cells.
http://www.omicsonline.org/celltherapy2012/scientific-program.php
Presentation abstract.....
David Kennan...VKIN's Chief Technology Officer.....
One way to occasionally get an advance look at any significant new developments is to monitor the website for any interesting changes.
In the last week or so, David Kennan's biography has been added to the management section of the VKIN website. Kennan was formerly the CTO of Logical Design Solutions......
RichieBoy...sub-penny shares, lack of interest, etc.....
Added to my position...name reservation renewed.....
Picked up 65+K of shares today at one cent.
Shaojun Sun renewed the "Sunrise Mining" name reservation at Nevada on July 16. This followed an almost 5-month period of time in which the name reservation had lapsed......
http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=TOSrX4JOKZmFqzxWZmB9fQ%253d%253d&nt7=0
SUIP/SGBL shell valuations.....
To the person who sent me a private message regarding the post (below) I made on another board in May 2012.......
VH1 July 30 press release....
The July 30 press release issued by VH1 has a pretty interesting mention of Awestruck Marketing.....
Awestruck press release...Comic-Con 2012, CEO picture.....
Awestruck Marketing put out its second press release a couple of weeks ago. It lists all of Awestruck's activities at this year's Comic-Con held in San Diego......
Jiao Xuding...June 2012 interview......
Jiao Xuding is mentioned in the first paragraph of this July 2012 Oil and Gas Financial Journal (Focus Reports) article.....
Nice Q1 2012 numbers......
Trailing 12-month numbers as of 3/31/2012.....
$25M revenue
$17M net income
.03 EPS
The China RM company has a tax exemption, so it is able to drop more money down to the bottom line. The very nature of the business will probably produce "lumpy/bumpy" results over shorter periods of comparisons, but it appears that some of the China/local government greening policies that were put in place during 2011 should produce some potentially nice growth for DION in the coming years. It also looks like they may be increasing efforts at some point to produce more "value-added" types of products (for example, edible oils, herbal products, etc) using their natural resource items.
It appears that the company's licenses and access to resources has become quite valuable due to market demand and significantly increasing prices on many of the plants/products the company is involved with.
Q1 2012 revenue.....
BaiHuaZhou website.....
The website for the RM company started coming online this past Saturday.
China version.....
http://www.baihuazhouchina.com/
English version.....
http://www.baihuazhouchina.com/e_index.asp#
tomsimeo...encouraging activity/developments.....
Based on the changes in content and language on SBAT's website and other related social media sites in the last 1-2 weeks, it appears to me that what is basically a full reverse merger of Viking Investments Group into Sinocubate (SBAT) has now been completed. Have all assets/liabilities and all global operational activities of Viking Investments Group now been transferred to SBAT?
I am hoping that is indeed the case, because in my opinion the "bits and pieces" kind of approach that has been taken up to this point has been needlessly confusing and frustrating from a retail investor standpoint. I realize that changing market conditions and other factors may have played a role in all of this, but it would have been nice to just see a relatively simple straight-forward reverse merger between SBAT and Viking right from the start.
I am assuming that you are waiting for the stock symbol change to take place before there is an increased amount of news flow, but hopefully in any upcoming press releases and the next 1-2 quarterly reports you can provide a very clear and detailed status of SBAT.
Some items I would like to see addressed relatively soon include.....
1) Updated, fully-diluted share structure following any transactions related to the transfer of these additional Viking assets/operations to SBAT. Also, any anticipated additional dilution or debt that might be associated with this transfer.
2) If there remains any part of Viking Nevis that hasn't been transferred, it needs to be fully disclosed and explained. Any current or anticipated/potential future relationship/agreements between SBAT and Viking Nevis (or parties related to Viking Nevis) need to be fully disclosed and explained.
3) Exact nature of and the reason for the establishment of a Series C preferred shares.
http://nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=1PiUL4VzUawEuEobAeh4Rw%253d%253d&CorpName=VIKING+INVESTMENTS+GROUP%2c+INC.
4) Any information related to the private placement you are preparing to do (as per SBAT's Facebook page, April 19).
bababooyah...CFON distribution.....
CFON...final liquidation distribution.....
Neuromics profile of James Musick......
Last paragraph of the Musick profile on Neuromics CEO Pete Shuster's blog......
Copower website updated...PDF file......
Ivan Rich...June 15 conference presentation.....
Hemogenix CEO Ivan Rich (VODG's strategic partner) will be the Chairman of the "Stem Cell and Bone Marrow Toxicity" session at the 10th International Conference on Early Toxicity Screening (June 14-15, Seattle).
Rich will also be making a presentation during this session.....
Musick...Twitter account activity begins......
CEO James Musick has had a Twitter account established for awhile now, but up until yesterday the only activity in his account was a single follower. Judging by the increase in activity starting yesterday, he will be making more use of this particular social media avenue in the future......
http://twitter.com/#!/VitroBiopharma
Somewhat interesting to note that Neuromics CEO Pete Shuster (VODG product distributor) and shakerzzz (well-known IHUB momentum player/trader) started following each other's Twitter accounts very recently (perhaps within the last few days).
Pete Shuster's Twitter account.....
http://twitter.com/#!/stratoman1
Neuromics blog...another post about Musick.....
Pete Shuster (CEO of Neuromics, a VODG product distributor) has made two posts about James Musick and Vitro Biopharma on his blog in the last two weeks.......
May 15.....
SU_IP(.002)...shell, 248K block changes hands......
6.9M shares outstanding
5.5M float
14K market cap
More than 3.5% of the SU_IP shell changed hands in an unusually large block of shares at .002 yesterday.
One of the brothers who owns/controls the SU_IP shell also owns/controls the SG_BL shell ($1.25 x $2, bid/ask). There is currently a huge disparity in valuations between these two shells.
There are differences in insider ownership between the shells, so to accurately compare the valuations of these shells you need to adjust the SU_IP share count up to 28.1M shares. A similiar valuation to SG_BL would place SU_IP's share price at around 15 cents.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=74163113
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=69177949
Endothelial differentiation medium.....
I am semi-expecting to see VODG at some point during 2012 make a new product announcement --- endothelial differentiation medium. Given the company's apparent increased interest in IR-related activity, I am anticipating VODG will issue a separate press release for this product whenever it is introduced.
The only disclosure that this particular/specific product is working its way through the company's product pipeline was this mention in the 2011 product catalog, which I posted about on another board last year.......
VODG(.055)...distributor increases product promotion......
Since about mid-April I have been noticing that CEO Pete Shuster of Neuromics (a VODG product distributor) has been actively promoting Vitro Biopharma's products. I'm not sure to what extent this will contribute to any meaningful/significant improvement in VODG revenue's but Schuster seems to be encouraged by the interest/feedback he has been receiving from customers. This should also gain VODG additional exposure to potential collaborators.
On Saturday morning Pete Shuster posted this on his blog......